Index of medicine substances

Emtricitabine + tenofovir disoproxil  •  Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations (J05AR03)

Enalapril  •  Cardiovascular system | Ace inhibitors, plain (C09AA02)

Enalapril + hydrochlorothiazide  •  Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and diuretics (C09BA02)

Enalapril + lercanidipine  •  Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and calcium channel blockers (C09BB02)

Enalapril + nitrendipine  •  Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and calcium channel blockers (C09BB06)

Encorafenib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | B-raf serine-threonine kinase (BRAF) inhibitors (L01EC03)

Enfortumab vedotin  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Other monoclonal antibodies and antibody drug conjugates (L01FX13)

Enfuvirtide  •  Antiinfectives for systemic use | Direct acting antivirals | Other antivirals (J05AX07)

Enoxaparin  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Heparin group (B01AB05)

Entacapone  •  Nervous system | Dopaminergic agents | Other dopaminergic agents (N04BX02)

Entecavir  •  Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors (J05AF10)

Entrectinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors (L01EX14)

Enzalutamide  •  Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Anti-androgens (L02BB04)

Epcoritamab  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Other monoclonal antibodies and antibody drug conjugates (L01FX27)

Ephanesoctocog alfa  •  Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors (B02BD02)

Ephedrine hydrochloride  •  Respiratory system | Adrenergics for systemic use | Alpha- and beta-adrenoreceptor agonists (R03CA02)

Ephedrine hydrochloride + hydrocortisone + naphazoline  •  Respiratory system | Decongestants and other nasal preparations for topical use | Corticosteroids (R01AD60)

Ephedrine + camphor + eucalyptus oil + peppermint oil + fennel oil + lemon oil + chlorobutanol  •  Respiratory system | Decongestants and other nasal preparations for topical use | Other nasal preparations (R01AX30)

Epinephrine  •  Cardiovascular system | Cardiac stimulants excluding cardiac glycosides | Adrenergic and dopaminergic agents (C01CA24)

Epirubicin  •  Antineoplastic and immunomodulating agents | Cytotoxic antibiotics and related substances | Anthracyclines and related substances (L01DB03)

Eplerenone  •  Cardiovascular system | Potassium-sparing agents | Aldosterone antagonists (C03DA04)

Eplontersen  •  Nervous system | Other nervous system drugs | Other nervous system drugs (N07XX21)

Epoetin alfa  •  Blood and blood forming organs | Other antianemic preparations (B03XA01)

Epoetin beta  •  Blood and blood forming organs | Other antianemic preparations (B03XA01)

Epoetin theta  •  Blood and blood forming organs | Other antianemic preparations (B03XA01)

Epoetin zeta  •  Blood and blood forming organs | Other antianemic preparations (B03XA01)

Epoprostenol  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin (B01AC09)

Eprosartan  •  Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain (C09CA02)

Eprosartan + hydrochlorothiazide  •  Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics (C09DA02)

Eptacog alpha activated  •  Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors (B02BD08)